[HTML][HTML] Colorectal liver metastases: Current management and future perspectives
J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - ncbi.nlm.nih.gov
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …
at least 25% developing colorectal liver metastases (CRLM) during the course of their …
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a …
T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov… - The lancet, 2015 - thelancet.com
Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …
[HTML][HTML] The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic …
Background Worldwide, both the incidence and death rates of pancreatic cancer are
increasing. Evaluation of pancreatic cancer burden and its global, regional, and national …
increasing. Evaluation of pancreatic cancer burden and its global, regional, and national …
Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016
Introduction Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity
and mortality. A comprehensive description of the global burden of MM is needed to help …
and mortality. A comprehensive description of the global burden of MM is needed to help …
[HTML][HTML] The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
Background Stomach cancer is a major health problem in many countries. Understanding
the current burden of stomach cancer and the differential trends across various locations is …
the current burden of stomach cancer and the differential trends across various locations is …
[HTML][HTML] The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
EM Alvarez, LM Force, R Xu, K Compton, D Lu… - The Lancet …, 2022 - thelancet.com
Background In estimating the global burden of cancer, adolescents and young adults with
cancer are often overlooked, despite being a distinct subgroup with unique epidemiology …
cancer are often overlooked, despite being a distinct subgroup with unique epidemiology …
[HTML][HTML] Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups …
Global Burden of Disease Cancer Collaboration - JAMA oncology, 2017 - ncbi.nlm.nih.gov
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With
Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 - PMC Back …
Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 - PMC Back …
[HTML][HTML] The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic …
GBD 2017 Oesophageal Cancer … - The lancet …, 2020 - ncbi.nlm.nih.gov
Background Oesophageal cancer is a common and often fatal cancer that has two main
histological subtypes: oesophageal squamous cell carcinoma and oesophageal …
histological subtypes: oesophageal squamous cell carcinoma and oesophageal …
The expanding role of primary care in cancer control
G Rubin, A Berendsen, SM Crawford… - The lancet …, 2015 - thelancet.com
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and
political demand, on prevention, early diagnosis, and patient experience during and after …
political demand, on prevention, early diagnosis, and patient experience during and after …
[HTML][HTML] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …
investigation for possible ovarian cancer in symptomatic women presenting to primary care …